A detailed history of Able Financial Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Able Financial Group, LLC holds 8,059 shares of ABT stock, worth $1.05 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
8,059
Previous 8,166 1.31%
Holding current value
$1.05 Million
Previous $1.11 Billion 99.9%
% of portfolio
0.25%
Previous 0.27%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025

SELL
$120.51 - $136.62 $12,894 - $14,618
-107 Reduced 1.31%
8,059 $1.08 Million
Q2 2025

Jul 14, 2025

BUY
$123.95 - $138.08 $62,222 - $69,316
502 Added 6.55%
8,166 $1.11 Billion
Q1 2025

Apr 25, 2025

BUY
$111.1 - $140.22 $24,664 - $31,128
222 Added 2.98%
7,664 $1.02 Billion
Q4 2024

Feb 27, 2025

BUY
$111.93 - $119.39 $9,961 - $10,625
89 Added 1.21%
7,442 $842 Million
Q3 2024

Oct 31, 2024

BUY
$100.07 - $118.13 $48,934 - $57,765
489 Added 7.12%
7,353 $838 Million
Q2 2024

Jul 26, 2024

BUY
$100.73 - $112.44 $235,305 - $262,659
2,336 Added 51.59%
6,864 $713 Million
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $9,747 - $10,765
-89 Reduced 1.93%
4,528 $515 Million
Q4 2023

Jan 24, 2024

SELL
$90.19 - $110.4 $306,285 - $374,918
-3,396 Reduced 42.38%
4,617 $508 Million
Q3 2023

Nov 07, 2023

SELL
$95.53 - $114.62 $815,157 - $978,052
-8,533 Reduced 51.57%
8,013 $776 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $245,399 - $273,426
2,435 Added 17.26%
16,546 $1.8 Billion
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $1.37 Million - $1.61 Million
14,111 New
14,111 $1.43 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Able Financial Group, LLC Portfolio

Follow Able Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Able Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Able Financial Group, LLC with notifications on news.